Sensei Biotherapeutics, Inc. (SNSE) Ownership

$9.01

$0.26 (-2.75%)
Last update: 01:00 PM EST
Day's range
$9.01
Day's range
$9.07

Sensei Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 05/09/2025 585.58 K $230.72 K   -1.49% 2.32%
IKARIAN CAPITAL, LLC 05/15/2025 449.96 K $177.29 K   -30.77% 1.79%
05/15/2025 294.37 K $115.98 K   0.00% 1.17%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 177.30 K $69.86 K   13.07% 0.70%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 150.71 K $59.39 K   1.22% 0.60%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 108.66 K $42.81 K   -37.12% 0.43%
UBS GROUP AG 05/13/2025 42.54 K $16.76 K   2,126,950.00% 0.17%
NORTHERN TRUST CORP 05/13/2025 25.98 K $10.24 K   0.00% 0.10%
STATE STREET CORP 05/15/2025 25.77 K $10.16 K   0.00% 0.10%
CRESSET ASSET MANAGEMENT, LLC 05/13/2025 19.67 K $7.75 K   0.00% 0.08%
RAYMOND JAMES FINANCIAL INC 05/13/2025 14.00 K $5.52 K   0.00% 0.06%
MORGAN STANLEY 05/15/2025 9.22 K $3.63 K   0.00% 0.04%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 5.40 K $2.13 K   -0.81% 0.02%
BARCLAYS PLC 05/15/2025 2.56 K $1.00 K   100.00% 0.01%
JPMORGAN CHASE & CO 05/12/2025 702 $276   -0.43% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 160 $63   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/15/2025 142 $56   4.41% 0.00%
CITIGROUP INC 05/12/2025 124 $49   100.00% 0.00%
05/02/2025 92 $36   29.58% 0.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 05/15/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 0 $0   -100.00% 0.00%
HRT FINANCIAL LP 05/15/2025 0 $0   -100.00% 0.00%
XTX TOPCO LTD 05/08/2025 0 $0   -100.00% 0.00%
DEUTERIUM CAPITAL MANAGEMENT, LLC 05/08/2025 0 $0   -100.00% 0.00%

Sensei Biotherapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 27 institutional investors and hedge funds held shares of Sensei Biotherapeutics, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 585,576

Ikarian Capital, LLC: 449,963

RENAISSANCE TECHNOLOGIES LLC: 177,300

GEODE CAPITAL MANAGEMENT, LLC: 150,709

BOOTHBAY FUND MANAGEMENT, LLC: 108,658

UBS Group AG: 42,541

7.59% of Sensei Biotherapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 1.66 M shares in the last 24 months. This purchase volume represents approximately $14.99 M in transactions.